Literature DB >> 22767654

Q fever: a case with a vascular infection complication.

Sophie Edouard1, Anne-Sophie Labussiere, Yves Guimard, Pierre-Edouard Fournier, Didier Raoult.   

Abstract

The most common clinical presentation of chronic Q fever is endocarditis with infections of aneurysms or vascular prostheses being the second most common presentation. Here, the authors report a case of vascular chronic Q fever. In this patient, a renal artery aneurysm was discovered by abdominal and pelvic CT during a systematic investigation to identify predisposing factors to chronic Q fever because of high antibody titres in a patient with valve disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 22767654      PMCID: PMC3027725          DOI: 10.1136/bcr.01.2010.2690

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  14 in total

1.  Risks factors and prevention of Q fever endocarditis.

Authors:  F Fenollar; P E Fournier; M P Carrieri; G Habib; T Messana; D Raoult
Journal:  Clin Infect Dis       Date:  2001-06-25       Impact factor: 9.079

Review 2.  [Q fever: current diagnosis and treatment options].

Authors:  M Million; H Lepidi; D Raoult
Journal:  Med Mal Infect       Date:  2008-11-14       Impact factor: 2.152

3.  Q fever 1985-1998. Clinical and epidemiologic features of 1,383 infections.

Authors:  D Raoult; H Tissot-Dupont; C Foucault; J Gouvernet; P E Fournier; E Bernit; A Stein; M Nesri; J R Harle; P J Weiller
Journal:  Medicine (Baltimore)       Date:  2000-03       Impact factor: 1.889

Review 4.  Q fever.

Authors:  D Raoult; T Marrie
Journal:  Clin Infect Dis       Date:  1995-03       Impact factor: 9.079

Review 5.  Coxiella burnetii infection of aneurysms or vascular grafts: report of seven cases and review.

Authors:  P E Fournier; J P Casalta; P Piquet; P Tournigand; A Branchereau; D Raoult
Journal:  Clin Infect Dis       Date:  1998-01       Impact factor: 9.079

6.  From acute Q fever to endocarditis: serological follow-up strategy.

Authors:  Cécile Landais; Florence Fenollar; Franck Thuny; Didier Raoult
Journal:  Clin Infect Dis       Date:  2007-04-04       Impact factor: 9.079

7.  Endocarditis after acute Q fever in patients with previously undiagnosed valvulopathies.

Authors:  Florence Fenollar; Franck Thuny; Bernard Xeridat; Hubert Lepidi; Didier Raoult
Journal:  Clin Infect Dis       Date:  2006-02-09       Impact factor: 9.079

8.  Coxiella burnetii infection of aortic aneurysms or vascular grafts: report of 30 new cases and evaluation of outcome.

Authors:  E Botelho-Nevers; P-E Fournier; H Richet; F Fenollar; H Lepidi; C Foucault; A Branchereau; P Piquet; M Maurin; D Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-09       Impact factor: 3.267

9.  Q fever serology: cutoff determination for microimmunofluorescence.

Authors:  H T Dupont; X Thirion; D Raoult
Journal:  Clin Diagn Lab Immunol       Date:  1994-03

10.  Quiescent Q fever endocarditis exacerbated by cardiac surgery and corticosteroid therapy.

Authors:  B I Lev; A Shachar; S Segev; P Weiss; E Rubinstein
Journal:  Arch Intern Med       Date:  1988-07
View more
  3 in total

Review 1.  From Q Fever to Coxiella burnetii Infection: a Paradigm Change.

Authors:  Carole Eldin; Cléa Mélenotte; Oleg Mediannikov; Eric Ghigo; Matthieu Million; Sophie Edouard; Jean-Louis Mege; Max Maurin; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

2.  Treatment and Prophylactic Strategy for Coxiella burnetii Infection of Aneurysms and Vascular Grafts: A Retrospective Cohort Study.

Authors:  Carole Eldin; Morgane Mailhe; Caroline Lions; Patrizia Carrieri; Hazem Safi; Philippe Brouqui; Didier Raoult
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

3.  Fluorescence In Situ Hybridization (FISH) and Peptide Nucleic Acid Probe-Based FISH for Diagnosis of Q Fever Endocarditis and Vascular Infections.

Authors:  Elsa Prudent; Hubert Lepidi; Emmanouil Angelakis; Didier Raoult
Journal:  J Clin Microbiol       Date:  2018-08-27       Impact factor: 11.677

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.